Biosceptre expression and purification strategy (BIF)
Project Member(s): Ralph, P.
Funding or Partner Organisation: Biosceptre (Aust) Pty Ltd (Biosceptre (Australia) Pty Ltd)
Biosceptre (Aust) Pty Ltd (Biosceptre (Australia) Pty Ltd)
Start year: 2022
Summary: Continuation of expression and purification strategy to prepare a panel of tumour antigen specific adaptor molecules (TASAMs) for the novel and universal adaptor CAR-T system (UAdCAR)
FOR Codes: Human pharmaceutical treatments , Medical molecular engineering of nucleic acids and proteins